EU regulator recommends to stop sale of GSK's blood cancer drug

  • 📰 SaltWire Network
  • ⏱ Reading Time:
  • 10 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 63%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

(Reuters) - The European Medicines Agency's human medicines committee on Friday recommended against renewal of the conditional marketing authorisation ...

- The European Medicines Agency's human medicines committee on Friday recommended against renewal of the conditional marketing authorisation for GSK's blood cancer drug Blenrep. (Reporting.

- The European Medicines Agency's human medicines committee on Friday recommended against renewal of the conditional marketing authorisation for GSK's blood cancer drug Blenrep. (Reporting
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 45. in HEALTH

Health Health Latest News, Health Health Headlines